麻豆原创

Search

Did you mean
destructive pulmonary
Your search for "obstructive pulmonary" gave back 9 results.

Global Asthma & COPD Therapeutics 麻豆原创 (By Type - Anti-inflammatory drugs (Inhaled Corticosteroids (ICS), Bronchodilator Monotherapy (Short-acting beta2-agonist (SABAs), Long-acting beta2-agonist (LABAs)), Others; By Nation 鈥� The US, Germany, France, Ja

Respiratory diseases refers to pathological condition affecting lungs and other parts of the respiratory system. Asthma and COPD are the two most...
颁补迟补濒辞驳:听
Pharma & Healthcare
Rockville Research
USA
Europe
Asia Pacific
May 2019
Price: USD 1,100.00

Asia Pacific Digital Respiratory Solutions 麻豆原创 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

Asia Pacific digital respiratory solutions market will grow by 41.6% annually with a total addressable market cap of $219.0 million over 2020-2030...
颁补迟补濒辞驳:听
Pharmaceutical Manufacturing
Grace 麻豆原创 Data
Asia Pacific
July 2020
Price: USD 2,800.00

Global Blood Preparation 麻豆原创 鈥� [(By Products 鈥� Whole Blood, Blood Derivatives & Blood Components; By Type 鈥� Platelet Aggregation Inhibitor, Fibrinolytic (Thrombolytic) & Anticoagulants; By Application 鈥� Thrombocytosis, Angina Blood Vessel Complications

Global Blood Preparation 麻豆原创 鈥� [(By Products 鈥� Whole Blood, Blood Derivatives & Blood Components; By Type 鈥� Platelet Aggregation Inhibitor,...
颁补迟补濒辞驳:听
Pharma & Healthcare
Rockville Research
USA
Europe
Asia Pacific
February 2019
Price: USD 1,100.00

Asia Pacific Pharmaceutical Contract Manufacturing 麻豆原创 2020-2030 by Category, Product (API, FDF), Phase (Clinical, Commercial), Type (Sterile, Non-Sterile), Therapeutic Application, and Country: Trend Forecast and Growth Opportunity

Asia Pacific pharmaceutical contract manufacturing market will grow by 7.6% annually with a total addressable market cap of $489.1 billion over 2020-...
颁补迟补濒辞驳:听
Pharmaceutical Manufacturing
Grace 麻豆原创 Data
Asia Pacific
October 2020
Price: USD 3,000.00

APAC Active Pharmaceutical Ingredients (API) 麻豆原创 2021-2028 by Synthesis , Manufacturing Process , Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

Asia Pacific active pharmaceutical ingredients market will grow by 8.8% annually with a total addressable market cap of $691.3 billion over 2021-2028...
颁补迟补濒辞驳:听
Pharmaceutical Manufacturing
Grace 麻豆原创 Data
Asia Pacific
February 2022
Price: USD 2,500.00

Asia Pacific Active Pharmaceutical Ingredients (API) 麻豆原创 2021-2027 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

Asia Pacific active pharmaceutical ingredients (API) market will grow by 9.0% annually with a total addressable market cap of $636.1 billion over...
颁补迟补濒辞驳:听
Research & Development (Pharma & Healthcare)
Grace 麻豆原创 Data
Asia Pacific
February 2021
Price: USD 2,480.00

Asia Pacific Active Pharmaceutical Ingredients (API) 麻豆原创 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

Asia Pacific active pharmaceutical ingredients (API) market will grow by 9.1% annually with a total addressable market cap of $584.2 billion over...
颁补迟补濒辞驳:听
Pharmaceutical Manufacturing
Grace 麻豆原创 Data
Asia Pacific
June 2020
Price: USD 2,480.00

Asia Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) 麻豆原创 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic Application, End User, and Country

Asia Pacific pharmaceutical CDMO market will grow by 8.3% annually with a total addressable market cap of $725.2 billion over 2020-2030 owing to the...
颁补迟补濒辞驳:听
Pharmaceutical Manufacturing
Grace 麻豆原创 Data
Asia Pacific
December 2020
Price: USD 3,300.00

Terumo Corporation - Strategy, SWOT and Corporate Finance Report

Terumo Corporation - Strategy, SWOT and Corporate Finance Report Summary Terumo Corporation - Strategy, SWOT and Corporate Finance Report, is a...
颁补迟补濒辞驳:听
Company Reports (Pharma & Healthcare)
麻豆原创Line
Japan
January 2023
Price: USD 175.00

Contact Us for Custom 麻豆原创 Research Solutions

听

Custom 麻豆原创 Research Reports

Clients Who Trust Us

麻豆原创 Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

Contact Us

About Us

At 麻豆原创 we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

麻豆原创 Research Reports, Inc
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected